北京大学学报(医学版) ›› 2015, Vol. 47 ›› Issue (5): 781-786. doi: 10.3969/j.issn.1671-167X.2015.05.009

• 论著 • 上一篇    下一篇

类风湿关节炎患者骨量改变危险因素分析及FRAX的应用价值

王昱,郝燕捷,邓雪蓉,李光韬,耿研,赵娟,周炜,张卓莉△   

  1. (北京大学第一医院风湿免疫科,北京100034)
  • 出版日期:2015-10-18 发布日期:2015-10-18
  • 通讯作者: 张卓莉 E-mail:zhuoli.zhang@126.com

Risk factors for bone mineral density changes in patients with rheumatoid arthritis and fracture risk assessment

WANG Yu, HAO Yan-jie, DENG Xue-rong, LI Guang-tao, GENG Yan, ZHAO Juan, ZHOU Wei, ZHANG Zhuo-li△   

  1. (Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing 100034, China)
  • Online:2015-10-18 Published:2015-10-18
  • Contact: ZHANG Zhuo-li E-mail:zhuoli.zhang@126.com

摘要:

目的:了解计算骨折危险性评估工具(fracture risk assessment tool,FRAX)时,使用与不使用骨密度(bone mineral density,BMD)对中国类风湿关节炎(rheumatoid arthritis,RA)患者骨折概率的影响,分析影响骨量的因素。方法:2009年12月至2012年12月于北京大学第一医院门诊及病房首次就诊的年龄大于40岁RA患者200例,双能X线测定腰椎和左髋部BMD,将使用与不使用BMD或T值计算的FRAX骨折概率进行比较,并结合患者的性别、年龄、绝经时间、体重指数、病程以及激素应用等因素进行相关性分析。结果:200例患者平均年龄(59.4±10.2)岁,77.5%为女性。有77例患者接受了双能X线检查,其中BMD正常和异常组分别为10例(13%)和67例(87%),有32例患者发生骨折。两组患者在平均年龄、糖皮质激素使用(用药时间、累积剂量、目前日平均剂量)、FRAX预测主要部位和髋部骨折风险之间差异均有统计学意义。使用与不使用BMD、T值计算的未来10年骨折概率差异无统计学差异。结合T值得出的FRAX预测骨折风险的ROC曲线下面积最大(0.899)。以腰椎及髋部的BMD作为结果变量,对影响患者BMD的因素进行多元回归分析显示:患者的疼痛评分(P=0.02)、既往发生骨折(P=0.003)、糖皮质激素的累积剂量(P=0.008)是引起腰椎骨量异常的危险因素,患者的年龄(P<0.001)、已绝经(P=0.05)、既往发生骨折(P=0.003)、体重指数(P=0.03)是引起左髋部骨量异常的危险因素。结论:RA患者骨折发生比例较高,主要部位和髋部骨折风险均增加,结合股骨颈BMD或T值计算FRAX能更有效地预测骨折概率。

关键词: 关节炎, 类风湿, 骨质疏松性骨折, 概率, 骨密度, 危险因素

Abstract:

Objective:To verify the fracture risk assessment tool (FRAX) to estimate the probability of osteoporotic fracture in patients with rheumatoid arthritis (RA) with or without bone mineral density (BMD), and identify associated risk factors of osteoporosis. Methods: In the study, 200 patients with rheumatoid arthritis aged more than 40 years in Peking University First Hospital from Dec. 2009 to Dec. 2012 were recruited. Clinical information was obtained from a questionnaire of their case history and medical records. FRAX tool was administered. Their lumber spine and left femoral BMD were determined by dual energy X ray absorptiometry. The gender, age, disease duration, menopause status, body mass index (BMI) and accumulative dose of glucocorticoid were obtained in retrospect. Correlation analysis was conducted between the BMD and clinical information. Results:The study population (female, 77.5%) had a mean age of 59.4 years, in which 10 (13%) patients showed a normal BMD, 67 (87%) were osteopenia or osteoporosis, while 32 patients (16%) had fragile fracture. Compared with the patients with normal BMD, the subjects with low BMD had significantly older age, longer period for corticoids usage, higher day dose and accumulated dose of corticoids.The 10-year fracture risk of sustai-ning major osteoporotic fractures and hip fracture was higher. No significant difference was observed between the 10-year fracture risks calculated with BMD and without BMD. The values of the different area under the receiver operating characteristic (ROC) curve (AUC) for major and hip fractures calculated in three ways: without BMD, with the femoral neck BMD, and with T-score. The best result was for FRAX tool for hip fracture with the T-score (AUC 0.899). A stepwise multivariate linear regression model was constructed to explore the relationship between the different clinical factors studied and a low BMD. Three statistically significant variables for lumber BMD were pain on visual assessment scale (VAS) (P=0.02), fracture history (P=0.003) and a higher steroid accumulated dose (P=0.008). Three statistically significant variables for left hip BMD were age (P<0.001), fracture history (P=0.05) and lower BMI (P=0.03). Conclusion: Low BMD is a common complication in RA patients. Risk factors for major fracture and hip fracture are increased. There is a positive correlation between FRAX calculated with and without BMD or T score. FRAX with the femoral neck T score or BMD presents a discriminatory capacity better than FRAX without BMD, according to the AUC ROC.

Key words: Arthritis, rheumatoid, Osteoporotic fractures, Probability, Bone density, Risk factors

中图分类号: 

  •  
[1] 李志存, 吴天俣, 梁磊, 范宇, 孟一森, 张骞. 穿刺活检单针阳性前列腺癌术后病理升级的危险因素分析及列线图模型构建[J]. 北京大学学报(医学版), 2024, 56(5): 896-901.
[2] 刘东武, 陈杰, 高明利, 于静. 类风湿关节炎伴发淋巴结Castleman样病理改变1例[J]. 北京大学学报(医学版), 2024, 56(5): 928-931.
[3] 颜野,李小龙,夏海缀,朱学华,张羽婷,张帆,刘可,刘承,马潞林. 前列腺癌根治术后远期膀胱过度活动症的危险因素[J]. 北京大学学报(医学版), 2024, 56(4): 589-593.
[4] 陈延,李况蒙,洪锴,张树栋,程建星,郑仲杰,唐文豪,赵连明,张海涛,姜辉,林浩成. 阴茎海绵体注射试验对阴茎血管功能影响的回顾性研究[J]. 北京大学学报(医学版), 2024, 56(4): 680-686.
[5] 庞博,郭桐君,陈曦,郭华棋,石嘉章,陈娟,王欣梅,李耀妍,单安琪,余恒意,黄婧,汤乃军,王艳,郭新彪,李国星,吴少伟. 天津与上海35岁以上人群氮氧化物个体暴露水平及其影响因素[J]. 北京大学学报(医学版), 2024, 56(4): 700-707.
[6] 和静,房中则,杨颖,刘静,马文瑶,霍勇,高炜,武阳丰,谢高强. 血浆中脂质代谢分子与颈动脉粥样硬化斑块、传统心血管危险因素及膳食因素的关系[J]. 北京大学学报(医学版), 2024, 56(4): 722-728.
[7] 李正芳,罗采南,武丽君,吴雪,孟新艳,陈晓梅,石亚妹,钟岩. 抗氨基甲酰化蛋白抗体在诊断类风湿关节炎中的应用价值[J]. 北京大学学报(医学版), 2024, 56(4): 729-734.
[8] 蔡珊,张依航,陈子玥,刘云飞,党佳佳,师嫡,李佳欣,黄天彧,马军,宋逸. 北京市中小学生身体活动时间现状及影响因素的路径[J]. 北京大学学报(医学版), 2024, 56(3): 403-410.
[9] 张祖洪,陈天娇,马军. 中小学生青春发动时相与心血管代谢危险因素的相关性[J]. 北京大学学报(医学版), 2024, 56(3): 418-423.
[10] 林郁婷,王华丽,田宇,巩俐彤,常春. 北京市老年人认知功能的影响因素[J]. 北京大学学报(医学版), 2024, 56(3): 456-461.
[11] 黄会娜,赵静,赵祥格,白自然,李霞,王冠. 乳酸对类风湿关节炎患者外周血CD4+T细胞亚群的调控作用[J]. 北京大学学报(医学版), 2024, 56(3): 519-525.
[12] 朱金荣,赵亚娜,黄巍,赵微微,王悦,王松,苏春燕. 感染新型冠状病毒的血液透析患者的临床特征[J]. 北京大学学报(医学版), 2024, 56(2): 267-272.
[13] 汤晓菲,李永红,丁秋玲,孙卓,张阳,王育梅,田美伊,刘坚. 类风湿关节炎患者下肢深静脉血栓发病率及危险因素[J]. 北京大学学报(医学版), 2024, 56(2): 279-283.
[14] 赖展鸿,李嘉辰,贠泽霖,张永刚,张昊,邢晓燕,邵苗,金月波,王乃迪,李依敏,李玉慧,栗占国. 特发性炎性肌病完全临床应答相关因素的单中心真实世界研究[J]. 北京大学学报(医学版), 2024, 56(2): 284-292.
[15] 司筱芊,赵秀娟,朱凤雪,王天兵. 创伤出血性休克后急性呼吸窘迫综合征的危险因素[J]. 北京大学学报(医学版), 2024, 56(2): 307-312.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!